Cargando...
Alzheimer's disease drug development pipeline: 2019
INTRODUCTION: Alzheimer's disease (AD) has few available treatments, and there is a high rate of failure in AD drug development programs. Study of the AD drug development pipeline can provide insight into the evolution of drug development and how best to optimize development practices. METHODS:...
Guardado en:
| Publicado en: | Alzheimers Dement (N Y) |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6617248/ https://ncbi.nlm.nih.gov/pubmed/31334330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2019.05.008 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|